Global Functional Dyspepsia Drug Market Growth 2022-2028
As the global economy mends, the 2021 growth of Functional Dyspepsia Drug will have significant change from previous year. According to our latest study, the global Functional Dyspepsia Drug market size is USD million in 2022 from USD 5819.5 million in 2021, with a change of % between 2021 and 2022. The global Functional Dyspepsia Drug market size will reach USD 7111 million in 2028, growing at a CAGR of 2.9% over the analysis period.
The United States Functional Dyspepsia Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Functional Dyspepsia Drug market, reaching US$ million by the year 2028. As for the Europe Functional Dyspepsia Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Functional Dyspepsia Drug players cover Bayer, Sumitomo, Cadila Pharmaceuticals, and Teva, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Functional Dyspepsia Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Prokinetic Drugs
Gastric Antisecretory Drugs
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Drugstores
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Bayer
Sumitomo
Cadila Pharmaceuticals
Teva
Johnson & Johnson
Pfizer
Sanofi
AstraZeneca
Jiangsu Aosaikang Pharma
Eisai
Kyowa Kirin Pharmaceuticals
Hanmi Pharm
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Functional Dyspepsia Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Functional Dyspepsia Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Functional Dyspepsia Drug by Country/Region, 2017, 2022 & 2028
2.2 Functional Dyspepsia Drug Segment by Type
2.2.1 Prokinetic Drugs
2.2.2 Gastric Antisecretory Drugs
2.2.3 Others
2.3 Functional Dyspepsia Drug Sales by Type
2.3.1 Global Functional Dyspepsia Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Functional Dyspepsia Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Functional Dyspepsia Drug Sale Price by Type (2017-2022)
2.4 Functional Dyspepsia Drug Segment by Application
2.4.1 Hospitals
2.4.2 Drugstores
2.5 Functional Dyspepsia Drug Sales by Application
2.5.1 Global Functional Dyspepsia Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Functional Dyspepsia Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Functional Dyspepsia Drug Sale Price by Application (2017-2022)
3 Global Functional Dyspepsia Drug by Company
3.1 Global Functional Dyspepsia Drug Breakdown Data by Company
3.1.1 Global Functional Dyspepsia Drug Annual Sales by Company (2020-2022)
3.1.2 Global Functional Dyspepsia Drug Sales Market Share by Company (2020-2022)
3.2 Global Functional Dyspepsia Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Functional Dyspepsia Drug Revenue by Company (2020-2022)
3.2.2 Global Functional Dyspepsia Drug Revenue Market Share by Company (2020-2022)
3.3 Global Functional Dyspepsia Drug Sale Price by Company
3.4 Key Manufacturers Functional Dyspepsia Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Functional Dyspepsia Drug Product Location Distribution
3.4.2 Players Functional Dyspepsia Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Functional Dyspepsia Drug by Geographic Region
4.1 World Historic Functional Dyspepsia Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Functional Dyspepsia Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Functional Dyspepsia Drug Annual Revenue by Geographic Region
4.2 World Historic Functional Dyspepsia Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Functional Dyspepsia Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Functional Dyspepsia Drug Annual Revenue by Country/Region
4.3 Americas Functional Dyspepsia Drug Sales Growth
4.4 APAC Functional Dyspepsia Drug Sales Growth
4.5 Europe Functional Dyspepsia Drug Sales Growth
4.6 Middle East & Africa Functional Dyspepsia Drug Sales Growth
5 Americas
5.1 Americas Functional Dyspepsia Drug Sales by Country
5.1.1 Americas Functional Dyspepsia Drug Sales by Country (2017-2022)
5.1.2 Americas Functional Dyspepsia Drug Revenue by Country (2017-2022)
5.2 Americas Functional Dyspepsia Drug Sales by Type
5.3 Americas Functional Dyspepsia Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Functional Dyspepsia Drug Sales by Region
6.1.1 APAC Functional Dyspepsia Drug Sales by Region (2017-2022)
6.1.2 APAC Functional Dyspepsia Drug Revenue by Region (2017-2022)
6.2 APAC Functional Dyspepsia Drug Sales by Type
6.3 APAC Functional Dyspepsia Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Functional Dyspepsia Drug by Country
7.1.1 Europe Functional Dyspepsia Drug Sales by Country (2017-2022)
7.1.2 Europe Functional Dyspepsia Drug Revenue by Country (2017-2022)
7.2 Europe Functional Dyspepsia Drug Sales by Type
7.3 Europe Functional Dyspepsia Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Functional Dyspepsia Drug by Country
8.1.1 Middle East & Africa Functional Dyspepsia Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Functional Dyspepsia Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Functional Dyspepsia Drug Sales by Type
8.3 Middle East & Africa Functional Dyspepsia Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Functional Dyspepsia Drug
10.3 Manufacturing Process Analysis of Functional Dyspepsia Drug
10.4 Industry Chain Structure of Functional Dyspepsia Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Functional Dyspepsia Drug Distributors
11.3 Functional Dyspepsia Drug Customer
12 World Forecast Review for Functional Dyspepsia Drug by Geographic Region
12.1 Global Functional Dyspepsia Drug Market Size Forecast by Region
12.1.1 Global Functional Dyspepsia Drug Forecast by Region (2023-2028)
12.1.2 Global Functional Dyspepsia Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Functional Dyspepsia Drug Forecast by Type
12.7 Global Functional Dyspepsia Drug Forecast by Application
13 Key Players Analysis
13.1 Bayer
13.1.1 Bayer Company Information
13.1.2 Bayer Functional Dyspepsia Drug Product Offered
13.1.3 Bayer Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Bayer Main Business Overview
13.1.5 Bayer Latest Developments
13.2 Sumitomo
13.2.1 Sumitomo Company Information
13.2.2 Sumitomo Functional Dyspepsia Drug Product Offered
13.2.3 Sumitomo Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sumitomo Main Business Overview
13.2.5 Sumitomo Latest Developments
13.3 Cadila Pharmaceuticals
13.3.1 Cadila Pharmaceuticals Company Information
13.3.2 Cadila Pharmaceuticals Functional Dyspepsia Drug Product Offered
13.3.3 Cadila Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Cadila Pharmaceuticals Main Business Overview
13.3.5 Cadila Pharmaceuticals Latest Developments
13.4 Teva
13.4.1 Teva Company Information
13.4.2 Teva Functional Dyspepsia Drug Product Offered
13.4.3 Teva Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Teva Main Business Overview
13.4.5 Teva Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Functional Dyspepsia Drug Product Offered
13.5.3 Johnson & Johnson Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 Pfizer
13.6.1 Pfizer Company Information
13.6.2 Pfizer Functional Dyspepsia Drug Product Offered
13.6.3 Pfizer Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Pfizer Main Business Overview
13.6.5 Pfizer Latest Developments
13.7 Sanofi
13.7.1 Sanofi Company Information
13.7.2 Sanofi Functional Dyspepsia Drug Product Offered
13.7.3 Sanofi Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Sanofi Main Business Overview
13.7.5 Sanofi Latest Developments
13.8 AstraZeneca
13.8.1 AstraZeneca Company Information
13.8.2 AstraZeneca Functional Dyspepsia Drug Product Offered
13.8.3 AstraZeneca Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 AstraZeneca Main Business Overview
13.8.5 AstraZeneca Latest Developments
13.9 Jiangsu Aosaikang Pharma
13.9.1 Jiangsu Aosaikang Pharma Company Information
13.9.2 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Product Offered
13.9.3 Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Jiangsu Aosaikang Pharma Main Business Overview
13.9.5 Jiangsu Aosaikang Pharma Latest Developments
13.10 Eisai
13.10.1 Eisai Company Information
13.10.2 Eisai Functional Dyspepsia Drug Product Offered
13.10.3 Eisai Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Eisai Main Business Overview
13.10.5 Eisai Latest Developments
13.11 Kyowa Kirin Pharmaceuticals
13.11.1 Kyowa Kirin Pharmaceuticals Company Information
13.11.2 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Product Offered
13.11.3 Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Kyowa Kirin Pharmaceuticals Main Business Overview
13.11.5 Kyowa Kirin Pharmaceuticals Latest Developments
13.12 Hanmi Pharm
13.12.1 Hanmi Pharm Company Information
13.12.2 Hanmi Pharm Functional Dyspepsia Drug Product Offered
13.12.3 Hanmi Pharm Functional Dyspepsia Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Hanmi Pharm Main Business Overview
13.12.5 Hanmi Pharm Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Functional Dyspepsia Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Functional Dyspepsia Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Prokinetic Drugs
Table 4. Major Players of Gastric Antisecretory Drugs
Table 5. Major Players of Others
Table 6. Global Functional Dyspepsia Drug Sales by Type (2017-2022) & (M Units)
Table 7. Global Functional Dyspepsia Drug Sales Market Share by Type (2017-2022)
Table 8. Global Functional Dyspepsia Drug Revenue by Type (2017-2022) & ($ million)
Table 9. Global Functional Dyspepsia Drug Revenue Market Share by Type (2017-2022)
Table 10. Global Functional Dyspepsia Drug Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Functional Dyspepsia Drug Sales by Application (2017-2022) & (M Units)
Table 12. Global Functional Dyspepsia Drug Sales Market Share by Application (2017-2022)
Table 13. Global Functional Dyspepsia Drug Revenue by Application (2017-2022)
Table 14. Global Functional Dyspepsia Drug Revenue Market Share by Application (2017-2022)
Table 15. Global Functional Dyspepsia Drug Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Functional Dyspepsia Drug Sales by Company (2020-2022) & (M Units)
Table 17. Global Functional Dyspepsia Drug Sales Market Share by Company (2020-2022)
Table 18. Global Functional Dyspepsia Drug Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Functional Dyspepsia Drug Revenue Market Share by Company (2020-2022)
Table 20. Global Functional Dyspepsia Drug Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Functional Dyspepsia Drug Producing Area Distribution and Sales Area
Table 22. Players Functional Dyspepsia Drug Products Offered
Table 23. Functional Dyspepsia Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Functional Dyspepsia Drug Sales by Geographic Region (2017-2022) & (M Units)
Table 27. Global Functional Dyspepsia Drug Sales Market Share Geographic Region (2017-2022)
Table 28. Global Functional Dyspepsia Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Functional Dyspepsia Drug Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Functional Dyspepsia Drug Sales by Country/Region (2017-2022) & (M Units)
Table 31. Global Functional Dyspepsia Drug Sales Market Share by Country/Region (2017-2022)
Table 32. Global Functional Dyspepsia Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Functional Dyspepsia Drug Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Functional Dyspepsia Drug Sales by Country (2017-2022) & (M Units)
Table 35. Americas Functional Dyspepsia Drug Sales Market Share by Country (2017-2022)
Table 36. Americas Functional Dyspepsia Drug Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Functional Dyspepsia Drug Revenue Market Share by Country (2017-2022)
Table 38. Americas Functional Dyspepsia Drug Sales by Type (2017-2022) & (M Units)
Table 39. Americas Functional Dyspepsia Drug Sales Market Share by Type (2017-2022)
Table 40. Americas Functional Dyspepsia Drug Sales by Application (2017-2022) & (M Units)
Table 41. Americas Functional Dyspepsia Drug Sales Market Share by Application (2017-2022)
Table 42. APAC Functional Dyspepsia Drug Sales by Region (2017-2022) & (M Units)
Table 43. APAC Functional Dyspepsia Drug Sales Market Share by Region (2017-2022)
Table 44. APAC Functional Dyspepsia Drug Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Functional Dyspepsia Drug Revenue Market Share by Region (2017-2022)
Table 46. APAC Functional Dyspepsia Drug Sales by Type (2017-2022) & (M Units)
Table 47. APAC Functional Dyspepsia Drug Sales Market Share by Type (2017-2022)
Table 48. APAC Functional Dyspepsia Drug Sales by Application (2017-2022) & (M Units)
Table 49. APAC Functional Dyspepsia Drug Sales Market Share by Application (2017-2022)
Table 50. Europe Functional Dyspepsia Drug Sales by Country (2017-2022) & (M Units)
Table 51. Europe Functional Dyspepsia Drug Sales Market Share by Country (2017-2022)
Table 52. Europe Functional Dyspepsia Drug Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Functional Dyspepsia Drug Revenue Market Share by Country (2017-2022)
Table 54. Europe Functional Dyspepsia Drug Sales by Type (2017-2022) & (M Units)
Table 55. Europe Functional Dyspepsia Drug Sales Market Share by Type (2017-2022)
Table 56. Europe Functional Dyspepsia Drug Sales by Application (2017-2022) & (M Units)
Table 57. Europe Functional Dyspepsia Drug Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Functional Dyspepsia Drug Sales by Country (2017-2022) & (M Units)
Table 59. Middle East & Africa Functional Dyspepsia Drug Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Functional Dyspepsia Drug Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Functional Dyspepsia Drug Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Functional Dyspepsia Drug Sales by Type (2017-2022) & (M Units)
Table 63. Middle East & Africa Functional Dyspepsia Drug Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Functional Dyspepsia Drug Sales by Application (2017-2022) & (M Units)
Table 65. Middle East & Africa Functional Dyspepsia Drug Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Functional Dyspepsia Drug
Table 67. Key Market Challenges & Risks of Functional Dyspepsia Drug
Table 68. Key Industry Trends of Functional Dyspepsia Drug
Table 69. Functional Dyspepsia Drug Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Functional Dyspepsia Drug Distributors List
Table 72. Functional Dyspepsia Drug Customer List
Table 73. Global Functional Dyspepsia Drug Sales Forecast by Region (2023-2028) & (M Units)
Table 74. Global Functional Dyspepsia Drug Sales Market Forecast by Region
Table 75. Global Functional Dyspepsia Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Functional Dyspepsia Drug Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Functional Dyspepsia Drug Sales Forecast by Country (2023-2028) & (M Units)
Table 78. Americas Functional Dyspepsia Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Functional Dyspepsia Drug Sales Forecast by Region (2023-2028) & (M Units)
Table 80. APAC Functional Dyspepsia Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Functional Dyspepsia Drug Sales Forecast by Country (2023-2028) & (M Units)
Table 82. Europe Functional Dyspepsia Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Functional Dyspepsia Drug Sales Forecast by Country (2023-2028) & (M Units)
Table 84. Middle East & Africa Functional Dyspepsia Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Functional Dyspepsia Drug Sales Forecast by Type (2023-2028) & (M Units)
Table 86. Global Functional Dyspepsia Drug Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Functional Dyspepsia Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Functional Dyspepsia Drug Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Functional Dyspepsia Drug Sales Forecast by Application (2023-2028) & (M Units)
Table 90. Global Functional Dyspepsia Drug Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Functional Dyspepsia Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Functional Dyspepsia Drug Revenue Market Share Forecast by Application (2023-2028)
Table 93. Bayer Basic Information, Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Bayer Functional Dyspepsia Drug Product Offered
Table 95. Bayer Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Bayer Main Business
Table 97. Bayer Latest Developments
Table 98. Sumitomo Basic Information, Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Sumitomo Functional Dyspepsia Drug Product Offered
Table 100. Sumitomo Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. Sumitomo Main Business
Table 102. Sumitomo Latest Developments
Table 103. Cadila Pharmaceuticals Basic Information, Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. Cadila Pharmaceuticals Functional Dyspepsia Drug Product Offered
Table 105. Cadila Pharmaceuticals Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. Cadila Pharmaceuticals Main Business
Table 107. Cadila Pharmaceuticals Latest Developments
Table 108. Teva Basic Information, Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 109. Teva Functional Dyspepsia Drug Product Offered
Table 110. Teva Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Teva Main Business
Table 112. Teva Latest Developments
Table 113. Johnson & Johnson Basic Information, Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. Johnson & Johnson Functional Dyspepsia Drug Product Offered
Table 115. Johnson & Johnson Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Johnson & Johnson Main Business
Table 117. Johnson & Johnson Latest Developments
Table 118. Pfizer Basic Information, Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 119. Pfizer Functional Dyspepsia Drug Product Offered
Table 120. Pfizer Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Pfizer Main Business
Table 122. Pfizer Latest Developments
Table 123. Sanofi Basic Information, Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 124. Sanofi Functional Dyspepsia Drug Product Offered
Table 125. Sanofi Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Sanofi Main Business
Table 127. Sanofi Latest Developments
Table 128. AstraZeneca Basic Information, Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 129. AstraZeneca Functional Dyspepsia Drug Product Offered
Table 130. AstraZeneca Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. AstraZeneca Main Business
Table 132. AstraZeneca Latest Developments
Table 133. Jiangsu Aosaikang Pharma Basic Information, Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 134. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Product Offered
Table 135. Jiangsu Aosaikang Pharma Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Jiangsu Aosaikang Pharma Main Business
Table 137. Jiangsu Aosaikang Pharma Latest Developments
Table 138. Eisai Basic Information, Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 139. Eisai Functional Dyspepsia Drug Product Offered
Table 140. Eisai Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Eisai Main Business
Table 142. Eisai Latest Developments
Table 143. Kyowa Kirin Pharmaceuticals Basic Information, Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 144. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Product Offered
Table 145. Kyowa Kirin Pharmaceuticals Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. Kyowa Kirin Pharmaceuticals Main Business
Table 147. Kyowa Kirin Pharmaceuticals Latest Developments
Table 148. Hanmi Pharm Basic Information, Functional Dyspepsia Drug Manufacturing Base, Sales Area and Its Competitors
Table 149. Hanmi Pharm Functional Dyspepsia Drug Product Offered
Table 150. Hanmi Pharm Functional Dyspepsia Drug Sales (M Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. Hanmi Pharm Main Business
Table 152. Hanmi Pharm Latest Developments
List of Figures
Figure 1. Picture of Functional Dyspepsia Drug
Figure 2. Functional Dyspepsia Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Functional Dyspepsia Drug Sales Growth Rate 2017-2028 (M Units)
Figure 7. Global Functional Dyspepsia Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Functional Dyspepsia Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Prokinetic Drugs
Figure 10. Product Picture of Gastric Antisecretory Drugs
Figure 11. Product Picture of Others
Figure 12. Global Functional Dyspepsia Drug Sales Market Share by Type in 2021
Figure 13. Global Functional Dyspepsia Drug Revenue Market Share by Type (2017-2022)
Figure 14. Functional Dyspepsia Drug Consumed in Hospitals
Figure 15. Global Functional Dyspepsia Drug Market: Hospitals (2017-2022) & (M Units)
Figure 16. Functional Dyspepsia Drug Consumed in Drugstores
Figure 17. Global Functional Dyspepsia Drug Market: Drugstores (2017-2022) & (M Units)
Figure 18. Global Functional Dyspepsia Drug Sales Market Share by Application (2017-2022)
Figure 19. Global Functional Dyspepsia Drug Revenue Market Share by Application in 2021
Figure 20. Functional Dyspepsia Drug Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Functional Dyspepsia Drug Revenue Market Share by Company in 2021
Figure 22. Global Functional Dyspepsia Drug Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Functional Dyspepsia Drug Revenue Market Share by Geographic Region in 2021
Figure 24. Global Functional Dyspepsia Drug Sales Market Share by Region (2017-2022)
Figure 25. Global Functional Dyspepsia Drug Revenue Market Share by Country/Region in 2021
Figure 26. Americas Functional Dyspepsia Drug Sales 2017-2022 (M Units)
Figure 27. Americas Functional Dyspepsia Drug Revenue 2017-2022 ($ Millions)
Figure 28. APAC Functional Dyspepsia Drug Sales 2017-2022 (M Units)
Figure 29. APAC Functional Dyspepsia Drug Revenue 2017-2022 ($ Millions)
Figure 30. Europe Functional Dyspepsia Drug Sales 2017-2022 (M Units)
Figure 31. Europe Functional Dyspepsia Drug Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Functional Dyspepsia Drug Sales 2017-2022 (M Units)
Figure 33. Middle East & Africa Functional Dyspepsia Drug Revenue 2017-2022 ($ Millions)
Figure 34. Americas Functional Dyspepsia Drug Sales Market Share by Country in 2021
Figure 35. Americas Functional Dyspepsia Drug Revenue Market Share by Country in 2021
Figure 36. United States Functional Dyspepsia Drug Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Functional Dyspepsia Drug Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Functional Dyspepsia Drug Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Functional Dyspepsia Drug Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Functional Dyspepsia Drug Sales Market Share by Region in 2021
Figure 41. APAC Functional Dyspepsia Drug Revenue Market Share by Regions in 2021
Figure 42. China Functional Dyspepsia Drug Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Functional Dyspepsia Drug Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Functional Dyspepsia Drug Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Functional Dyspepsia Drug Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Functional Dyspepsia Drug Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Functional Dyspepsia Drug Revenue Growth 2017-2022 ($ Millions)
Figure 48. Europe Functional Dyspepsia Drug Sales Market Share by Country in 2021
Figure 49. Europe Functional Dyspepsia Drug Revenue Market Share by Country in 2021
Figure 50. Germany Functional Dyspepsia Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. France Functional Dyspepsia Drug Revenue Growth 2017-2022 ($ Millions)
Figure 52. UK Functional Dyspepsia Drug Revenue Growth 2017-2022 ($ Millions)
Figure 53. Italy Functional Dyspepsia Drug Revenue Growth 2017-2022 ($ Millions)
Figure 54. Russia Functional Dyspepsia Drug Revenue Growth 2017-2022 ($ Millions)
Figure 55. Middle East & Africa Functional Dyspepsia Drug Sales Market Share by Country in 2021
Figure 56. Middle East & Africa Functional Dyspepsia Drug Revenue Market Share by Country in 2021
Figure 57. Egypt Functional Dyspepsia Drug Revenue Growth 2017-2022 ($ Millions)
Figure 58. South Africa Functional Dyspepsia Drug Revenue Growth 2017-2022 ($ Millions)
Figure 59. Israel Functional Dyspepsia Drug Revenue Growth 2017-2022 ($ Millions)
Figure 60. Turkey Functional Dyspepsia Drug Revenue Growth 2017-2022 ($ Millions)
Figure 61. GCC Country Functional Dyspepsia Drug Revenue Growth 2017-2022 ($ Millions)
Figure 62. Manufacturing Cost Structure Analysis of Functional Dyspepsia Drug in 2021
Figure 63. Manufacturing Process Analysis of Functional Dyspepsia Drug
Figure 64. Industry Chain Structure of Functional Dyspepsia Drug
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
